1. Home
  2. KALV vs JBI Comparison

KALV vs JBI Comparison

Compare KALV & JBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$5.22

Market Cap

987.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
JBI
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
987.0M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KALV
JBI
Price
$26.68
$5.22
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$32.60
$9.17
AVG Volume (30 Days)
2.7M
1.2M
Earning Date
07-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$9.36
Revenue Next Year
$59.23
$3.16
P/E Ratio
N/A
$13.75
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$4.75
52 Week High
$26.76
$10.80

Technical Indicators

Market Signals
Indicator
KALV
JBI
Relative Strength Index (RSI) 75.31 42.48
Support Level $14.43 $5.07
Resistance Level N/A $5.76
Average True Range (ATR) 0.97 0.20
MACD 0.53 0.01
Stochastic Oscillator 99.01 3.70

Price Performance

Historical Comparison
KALV
JBI

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

Share on Social Networks: